Paul Z Zimmet

Author PubWeight™ 218.59‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009 35.24
2 The metabolic syndrome. Lancet 2005 19.47
3 Breaks in sedentary time: beneficial associations with metabolic risk. Diabetes Care 2008 8.04
4 Objectively measured sedentary time, physical activity, and metabolic risk: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Diabetes Care 2007 6.95
5 The worldwide epidemiology of type 2 diabetes mellitus--present and future perspectives. Nat Rev Endocrinol 2011 5.55
6 Objectively measured light-intensity physical activity is independently associated with 2-h plasma glucose. Diabetes Care 2007 5.20
7 Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Circulation 2007 4.97
8 The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 2002 4.52
9 Breaking up prolonged sitting reduces postprandial glucose and insulin responses. Diabetes Care 2012 4.50
10 Prevalence of kidney damage in Australian adults: The AusDiab kidney study. J Am Soc Nephrol 2003 4.15
11 Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet 2014 4.13
12 Television time and continuous metabolic risk in physically active adults. Med Sci Sports Exerc 2008 3.58
13 The metabolic syndrome. Lancet 2010 3.47
14 Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci. Nat Genet 2011 3.46
15 Overweight and obesity in Australia: the 1999-2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Med J Aust 2003 3.24
16 The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am 2004 3.20
17 The Australian Diabetes, Obesity and Lifestyle Study (AusDiab)--methods and response rates. Diabetes Res Clin Pract 2002 3.18
18 Association of television viewing with fasting and 2-h postchallenge plasma glucose levels in adults without diagnosed diabetes. Diabetes Care 2007 2.82
19 Deleterious associations of sitting time and television viewing time with cardiometabolic risk biomarkers: Australian Diabetes, Obesity and Lifestyle (AusDiab) study 2004-2005. Diabetes Care 2009 2.57
20 Physical activity and television viewing in relation to risk of undiagnosed abnormal glucose metabolism in adults. Diabetes Care 2004 2.55
21 AUSDRISK: an Australian Type 2 Diabetes Risk Assessment Tool based on demographic, lifestyle and simple anthropometric measures. Med J Aust 2010 2.44
22 The prevalence of and factors associated with diabetic retinopathy in the Australian population. Diabetes Care 2003 2.33
23 Glucose indices, health behaviors, and incidence of diabetes in Australia: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 2007 2.30
24 Sleep-disordered breathing and type 2 diabetes: a report from the International Diabetes Federation Taskforce on Epidemiology and Prevention. Diabetes Res Clin Pract 2008 2.30
25 A single factor underlies the metabolic syndrome: a confirmatory factor analysis. Diabetes Care 2006 2.22
26 Longitudinal association of glucose metabolism with retinopathy: results from the Australian Diabetes Obesity and Lifestyle (AusDiab) study. Diabetes Care 2008 2.09
27 Albuminuria is evident in the early stages of diabetes onset: results from the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Am J Kidney Dis 2004 1.94
28 Is haemoglobin A1c a step forward for diagnosing diabetes? BMJ 2009 1.82
29 The cost of overweight and obesity in Australia. Med J Aust 2010 1.77
30 Increased cardiometabolic risk is associated with increased TV viewing time. Med Sci Sports Exerc 2010 1.68
31 Serum 25-hydroxyvitamin D, calcium intake, and risk of type 2 diabetes after 5 years: results from a national, population-based prospective study (the Australian Diabetes, Obesity and Lifestyle study). Diabetes Care 2011 1.67
32 Socio-demographic correlates of prolonged television viewing time in Australian men and women: the AusDiab study. J Phys Act Health 2010 1.64
33 Associations between television viewing time and overall sitting time with the metabolic syndrome in older men and women: the Australian Diabetes, Obesity and Lifestyle study. J Am Geriatr Soc 2011 1.63
34 Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: modeling the long-term health economic implications of the diabetes prevention program in Australia, France, Germany, Switzerland, and the United Kingdom. Clin Ther 2004 1.60
35 Prevalence of the metabolic syndrome among 40,698 Korean metropolitan subjects. Diabetes Res Clin Pract 2004 1.46
36 Low serum 25-hydroxyvitamin D is associated with increased risk of the development of the metabolic syndrome at five years: results from a national, population-based prospective study (The Australian Diabetes, Obesity and Lifestyle Study: AusDiab). J Clin Endocrinol Metab 2012 1.45
37 How do the Australian guidelines for lipid-lowering drugs perform in practice? Cardiovascular disease risk in the AusDiab Study, 1999-2000. Med J Aust 2008 1.45
38 Untreated hypertension among Australian adults: the 1999-2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Med J Aust 2003 1.44
39 Prevalence of vitamin D deficiency and its determinants in Australian adults aged 25 years and older: a national, population-based study. Clin Endocrinol (Oxf) 2012 1.43
40 Can we avert a diabetes catastrophe in Australia? Med J Aust 2013 1.39
41 The metabolic syndrome in Australia: prevalence using four definitions. Diabetes Res Clin Pract 2007 1.32
42 Glucose, lipid, and blood pressure control in Australian adults with type 2 diabetes: the 1999-2000 AusDiab. Diabetes Care 2005 1.31
43 Tanis: a link between type 2 diabetes and inflammation? Diabetes 2002 1.30
44 Retinal arteriolar caliber predicts incident retinopathy: the Australian Diabetes, Obesity and Lifestyle (AusDiab) study. Diabetes Care 2008 1.29
45 Prevalence of albuminuria in Australia: the AusDiab Kidney Study. Kidney Int Suppl 2004 1.26
46 Retinal arteriolar narrowing predicts incidence of diabetes: the Australian Diabetes, Obesity and Lifestyle (AusDiab) Study. Diabetes 2007 1.26
47 How to best define the metabolic syndrome. Ann Med 2006 1.25
48 Health-related quality of life in Australian adults with renal insufficiency: a population-based study. Am J Kidney Dis 2003 1.24
49 Beneficial associations of physical activity with 2-h but not fasting blood glucose in Australian adults: the AusDiab study. Diabetes Care 2006 1.21
50 Mortality, all-cause and cardiovascular disease, over 15 years in multiethnic mauritius: impact of diabetes and intermediate forms of glucose tolerance. Diabetes Care 2010 1.21
51 The influence of hip circumference on the relationship between abdominal obesity and mortality. Int J Epidemiol 2012 1.21
52 Central obesity as a precursor to the metabolic syndrome in the AusDiab study and Mauritius. Obesity (Silver Spring) 2008 1.19
53 Decline in physical fitness from childhood to adulthood associated with increased obesity and insulin resistance in adults. Diabetes Care 2008 1.13
54 Glucose-independent ethnic differences in HbA1c in people without known diabetes. Diabetes Care 2012 1.12
55 Six year incidence and progression of diabetic retinopathy: results from the Mauritius diabetes complication study. Diabetes Res Clin Pract 2006 1.10
56 International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes: response to the International Expert Committee. Diabetes Care 2009 1.08
57 Does high-intensity resistance training maintain bone mass during moderate weight loss in older overweight adults with type 2 diabetes? Osteoporos Int 2005 1.06
58 Retinopathy in persons with impaired glucose metabolism: the Australian Diabetes Obesity and Lifestyle (AusDiab) study. Am J Ophthalmol 2005 1.06
59 Diabetes care in an Australian population: frequency of screening examinations for eye and foot complications of diabetes. Diabetes Care 2004 1.03
60 Projecting the burden of diabetes in Australia--what is the size of the matter? Aust N Z J Public Health 2009 1.02
61 Association between impaired glucose metabolism and quality of life: results from the Australian diabetes obesity and lifestyle study. Diabetes Res Clin Pract 2006 1.02
62 Cut-points for waist circumference in Europids and South Asians. Obesity (Silver Spring) 2009 0.99
63 Area-level socioeconomic status and incidence of abnormal glucose metabolism: the Australian Diabetes, Obesity and Lifestyle (AusDiab) study. Diabetes Care 2012 0.98
64 Association between albuminuria and proteinuria in the general population: the AusDiab Study. Nephrol Dial Transplant 2003 0.98
65 Health and mortality consequences of abdominal obesity: evidence from the AusDiab study. Med J Aust 2009 0.97
66 HbA1c, fasting and 2 h plasma glucose in current, ex- and never-smokers: a meta-analysis. Diabetologia 2013 0.97
67 Is peripheral neuropathy associated with retinopathy and albuminuria in individuals with impaired glucose metabolism? The 1999-2000 AusDiab. Diabetes Care 2006 0.94
68 Is there a link between components of health-related functioning and incident impaired glucose metabolism and type 2 diabetes? The Australian Diabetes Obesity and Lifestyle (AusDiab) study. Diabetes Care 2009 0.94
69 Mainstreaming the metabolic syndrome: a definitive definition. Med J Aust 2005 0.94
70 BMI compared with central obesity indicators as a predictor of diabetes incidence in Mauritius. Obesity (Silver Spring) 2008 0.93
71 High rates of albuminuria but not of low eGFR in urban indigenous Australians: the DRUID study. BMC Public Health 2011 0.92
72 Genetic variation in BEACON influences quantitative variation in metabolic syndrome-related phenotypes. Diabetes 2004 0.90
73 Anthropometric measures and absolute cardiovascular risk estimates in the Australian Diabetes, Obesity and Lifestyle (AusDiab) Study. Eur J Cardiovasc Prev Rehabil 2007 0.90
74 Expanding evidence for the multiple dangers of epidemic abdominal obesity. Circulation 2008 0.89
75 Point: impaired fasting glucose: The case for the new American Diabetes Association criterion. Diabetes Care 2006 0.89
76 Maternal diet during pregnancy and islet autoimmunity in offspring. Pediatr Diabetes 2008 0.89
77 Population prevalence of albuminuria in the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study: immunonephelometry compared with high-performance liquid chromatography. Am J Kidney Dis 2006 0.89
78 Explaining the increase of diabetes prevalence and plasma glucose in Mauritius. Diabetes Care 2011 0.89
79 The unstoppable Australian obesity and diabetes juggernaut. what should politicians do? Med J Aust 2006 0.88
80 Associations of strength training with impaired glucose metabolism: the AusDiab Study. Med Sci Sports Exerc 2013 0.87
81 Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome. Hum Reprod 2008 0.86
82 Independent association of hip circumference with metabolic profile in different ethnic groups. Obes Res 2004 0.86
83 Frequent walking, but not total physical activity, is associated with increased fracture incidence: a 5-year follow-up of an Australian population-based prospective study (AusDiab). J Bone Miner Res 2011 0.85
84 Profile of dyslipidemia in Psammomys obesus, an animal model of the metabolic syndrome. Endocr Regul 2002 0.83
85 Joint associations of poor diet quality and prolonged television viewing time with abnormal glucose metabolism in Australian men and women. Prev Med 2013 0.82
86 Objectively measured physical activity and the subsequent risk of incident dysglycemia: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Diabetes Care 2011 0.81
87 Waist circumference has heterogeneous impact on development of diabetes in different populations: longitudinal comparative study between Australia and Iran. Diabetes Res Clin Pract 2010 0.79
88 The GIANT study, a cluster-randomised controlled trial of efficacy of education of doctors about type 2 diabetes mellitus management guidelines in primary care practice. Diabetes Res Clin Pract 2012 0.79
89 A prospective study of glycemia, body size, insulin resistance and the risk of hypertension in Mauritius. J Hypertens 2008 0.79
90 Physical activity, television viewing time, and retinal vascular caliber. Med Sci Sports Exerc 2011 0.78
91 Dietary toxins, endoplasmic reticulum (ER) stress and diabetes. Curr Diabetes Rev 2008 0.78
92 The effects of repeated exposure to sub-toxic doses of plecomacrolide antibiotics on the endocrine pancreas. Food Chem Toxicol 2006 0.78
93 Diabetic kidney disease: act now or pay later. Med J Aust 2010 0.77
94 Prevalence and treatment of cardiovascular disease and traditional risk factors in Australian adults with renal insufficiency. Nephrology (Carlton) 2005 0.77
95 The PEVKEK region of the pyridoxal phosphate binding domain of GAD65 expresses a dominant B cell epitope for type 1 diabetes sera. Ann N Y Acad Sci 2002 0.76
96 All-cause cancer mortality over 15 years in multi-ethnic Mauritius: the impact of diabetes and intermediate forms of glucose tolerance. Int J Cancer 2012 0.76
97 Metabolic syndrome-do we really need a new definition? Metab Syndr Relat Disord 2005 0.76
98 HPLC-detected albuminuria predicts mortality. J Am Soc Nephrol 2007 0.75
99 Designing payments for GPs to improve the quality of diabetes care. Med J Aust 2012 0.75
100 Estimating cardiovascular disease risk in diabetes. Lancet 2006 0.75
101 Toxic type 1 diabetes. Rev Endocr Metab Disord 2003 0.75
102 The performance of diabetes risk prediction models in new populations: the role of ethnicity of the development cohort. Acta Diabetol 2014 0.75
103 Reflections on the Evolving Global Diabetes Epidemic: A Conversation With Paul Z. Zimmet, MBBS, MD, PhD. Circulation 2019 0.75
104 Transplacental exposure to the vacuolar-ATPase inhibitor bafilomycin disrupts survival signaling in beta cells and delays neonatal remodeling of the endocrine pancreas. Exp Toxicol Pathol 2008 0.75
105 Ability of GHTD-amide and analogs to enhance insulin activity through zinc chelation and dispersal of insulin oligomers. Peptides 2009 0.75